https://williamscancerinstitute.com/wp-content/uploads/2023/06/blog-23-de-junio-horizontal.png353568Dr, Jason R Williamshttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngDr, Jason R Williams2023-06-23 12:10:242023-06-23 12:10:24Tertiary Lymphoid Structures Predict Immune Response and Can Be Detected by CT Imaging
https://williamscancerinstitute.com/wp-content/uploads/2023/06/horizontal-blog-21-de-junio.png353568Dr, Jason R Williamshttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngDr, Jason R Williams2023-06-21 12:09:002023-06-22 12:54:20Improving immune checkpoint inhibitors anti-tumor response
https://williamscancerinstitute.com/wp-content/uploads/2023/04/horizontal-blog-19-de-abril-1.png353568Dr, Jason R Williamshttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngDr, Jason R Williams2023-04-19 16:51:232023-06-22 14:28:44Reprogramming Neutrophils to Enhance Cancer Immunotherapy
https://williamscancerinstitute.com/wp-content/uploads/2023/01/new-news-horizontal.png353568webmasterhttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngwebmaster2023-01-24 15:51:292023-06-22 17:20:11New Immunotherapy Combination Improves Survival in Metastatic Lung Cancer by 63%